| Dr Ryan Le Sparkman, MD | |
|
800 Scott And White Dr, College Station, TX 77845-6440 | |
| (254) 724-0932 | |
| Not Available |
| Full Name | Dr Ryan Le Sparkman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 800 Scott And White Dr, College Station, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407016827 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center- College Stati | College station, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
Researchers searching for signs of Middle East respiratory syndrome coronavirus in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious Diseases, suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans.
In its recently published 5th issue, the Journal of Unsolved Questions (JUnQ) invites readers to take a look behind the doors of researchers' offices and laboratories, presenting "reports from the academic workforce". Researchers from archeology to neurology were invited to reflect upon "Scientific Labor". With this cover topic, JUnQ continues its endeavor to promote a realistic view of academic work.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
› Verified 8 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Researchers searching for signs of Middle East respiratory syndrome coronavirus in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious Diseases, suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans.
In its recently published 5th issue, the Journal of Unsolved Questions (JUnQ) invites readers to take a look behind the doors of researchers' offices and laboratories, presenting "reports from the academic workforce". Researchers from archeology to neurology were invited to reflect upon "Scientific Labor". With this cover topic, JUnQ continues its endeavor to promote a realistic view of academic work.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
› Verified 8 days ago
| Entity Name | Scott & White Hospital Brenham |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295464949 PECOS PAC ID: 5799719787 Enrollment ID: O20220719002610 |
News Archive
Researchers searching for signs of Middle East respiratory syndrome coronavirus in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious Diseases, suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans.
In its recently published 5th issue, the Journal of Unsolved Questions (JUnQ) invites readers to take a look behind the doors of researchers' offices and laboratories, presenting "reports from the academic workforce". Researchers from archeology to neurology were invited to reflect upon "Scientific Labor". With this cover topic, JUnQ continues its endeavor to promote a realistic view of academic work.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Le Sparkman, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Dr Ryan Le Sparkman, MD 800 Scott And White Dr, College Station, TX 77845-6440 Ph: (254) 724-0932 |
News Archive
Researchers searching for signs of Middle East respiratory syndrome coronavirus in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious Diseases, suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans.
In its recently published 5th issue, the Journal of Unsolved Questions (JUnQ) invites readers to take a look behind the doors of researchers' offices and laboratories, presenting "reports from the academic workforce". Researchers from archeology to neurology were invited to reflect upon "Scientific Labor". With this cover topic, JUnQ continues its endeavor to promote a realistic view of academic work.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
› Verified 8 days ago
Dr. Jared Dean Anderson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000 Fax: 979-207-4562 | |
Cory Brenson Burrough, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Dr. Adam Connell Jenkins, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000 | |
Chloe Agnes Ntaimo, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 2007 Ravenstone Loop, College Station, TX 77845 Phone: 979-690-9434 | |
Laura M Garrett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Edward D Schmidt, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-691-3300 | |
Jeu B Dott Jr., MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8700 Redwood St, College Station, TX 77845 Phone: 979-693-7167 Fax: 979-696-7111 |